12:00 AM
 | 
May 24, 1999
 |  BC Week In Review  |  Clinical News  |  Clinical Results

ZD0473: Phase I

Preliminary data from 27 patients showed that ZD0473 did not have serious toxicities that are associated with cisplatin. But dose-limiting thrombocytopenia was seen at 130 mg/m2...

Read the full 110 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >